Clinical Trial Supply and Logistics Market –Global Industry Insights 2026 With Major Key Companies Catalent Pharma Solutions, Almac Group, Movianto, Patheon, PCI Pharma Distribution

CMI released a new market study on 2017-2025 Clinical Trial Supply and Logistics Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for 2017-2025 Clinical Trial Supply and Logistics Market Forecast till 2025*.

Clinical trial supply and logistics is a management that is responsible for providing clinical supplies needed for clinical studies of drugs or medical devices in accordance with protocol and applicable regulatory requirements. This process involves oversight of the planning, packaging, forecasting, labeling, sourcing, distribution, and clinical supplies for government and commercial sponsors whose studies are in phase 1-4 clinical trials. Clinical trial suppliers integrate with many third party vendors and technicians to verify whether study drugs available are in sufficient quantity and quality at various stages of clinical distribution. This management, in terms of drug supply, offers full traceability from manufacturing to dispensation and destruction, which in turn reduces risks such as expiration or out of stock of products.

"The global clinical trial supply and logistics market size was valued at US$ 14.95 Bn in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026)."

Get PDF for more Professional and Technical insights@ https://www.coherentmarketinsights.com/insight/request-sample/1798

This report provides in-depth analysis of the clinical trial supply and logistics market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2016 – 2026, considering 2017 as the base year.It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players.It profiles leading players in the global clinical trial supply and logistics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies.Key players covered as a part of this study include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair.

Continuous emphasis by the manufacturers towards balancing shipment and supply costs, optimizing production and packaging and minimizing overage and avoiding shortages, are propelling the demand for efficient solutions for clinical trial supply and logistics. Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will also augment the demand for regional depot network with strong transport networks to trial sites.

Market Dynamics

Increase in number of registered clinical trials across the regions is also expected to spur the demand of clinical trial supply and logistics market during the forecast period. Various online sources suggest that the Brazil holds the second most registered clinical trials among the BRIC (Brazil, Russia, India and China) countries, with a share of approximately 2% of the global volume. Furthermore, vendors are also focussing on launching different clinical programs to market their services and attract more clients and government to partnership with them. For instance, in June 2018, Bionical Group Ltd launched Bionical-Clinical Early Access Programs (EAP) which connect established and successful Clinical Research Organization to support large and small scale Pharma and Biotech industries enabling, appropriate treatment access to patients in desperate need.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1798

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.